APA

O'Day S., Pavlick A., Loquai C., Lawson D., Gutzmer R., Richards J., Schadendorf D., Thompson J. A., Gonzalez R., Trefzer U., Mohr P., Ottensmeier C., Chao D., Zhong B., de Boer C. J., Uhlar C., Marshall D., Gore M. E., Lang Z., Hait W. & Ho P. (20110916). A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. : British journal of cancer.

Chicago

O'Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson J A, Gonzalez R, Trefzer U, Mohr P, Ottensmeier C, Chao D, Zhong B, de Boer C J, Uhlar C, Marshall D, Gore M E, Lang Z, Hait W and Ho P. 20110916. A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. : British journal of cancer.

Harvard

O'Day S., Pavlick A., Loquai C., Lawson D., Gutzmer R., Richards J., Schadendorf D., Thompson J. A., Gonzalez R., Trefzer U., Mohr P., Ottensmeier C., Chao D., Zhong B., de Boer C. J., Uhlar C., Marshall D., Gore M. E., Lang Z., Hait W. and Ho P. (20110916). A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. : British journal of cancer.

MLA

O'Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson J A, Gonzalez R, Trefzer U, Mohr P, Ottensmeier C, Chao D, Zhong B, de Boer C J, Uhlar C, Marshall D, Gore M E, Lang Z, Hait W and Ho P. A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. : British journal of cancer. 20110916.